BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, May 4, 2026
Home » Topics » Briefs » Appointments and advancements

Appointments and advancements
Appointments and advancements RSS Feed RSS

Appointments and advancements for April 25, 2024

April 25, 2024
New hires and promotions in the med-tech industry, including: Conmed, Lumabridge.
Read More

Appointments and advancements for April 24, 2024

April 24, 2024
New hires and promotions in the biopharma industry, including: Actym, Cel-Sci, Curevac, Evotec, Flare, Harness, Oruka, Pharmaessentia, Recludix.
Read More

Appointments and advancements for April 24, 2024

April 24, 2024
New hires and promotions in the med-tech industry, including: Bioaffinity, Seed Health, Spectral AI, Spectral IP, Techwald, Valcare, Vantage Medtech.
Read More

Appointments and advancements for April 23, 2024

April 23, 2024
New hires and promotions in the biopharma industry, including: Anthos, Calluna, LSL, Proqr, Seamless, Sygnature Discovery.
Read More

Appointments and advancements for April 23, 2024

April 23, 2024
New hires and promotions in the med-tech industry, including: Cel-Sci.
Read More

Appointments and advancements for April 23, 2024

April 23, 2024
New hires and promotions in the med-tech industry in Asia-Pacific, including: Shionogi.
Read More

Appointments and advancements for April 22, 2024

April 22, 2024
New hires and promotions in the biopharma industry, including: Amarna, Bausch + Lomb, Kalvista, Mirror, Sernova.
Read More

Appointments and advancements for April 22, 2024

April 22, 2024
New hires and promotions in the med-tech industry, including: Iveacare, Rhythmlink, Zeus.
Read More

Appointments and advancements for April 19, 2024

April 19, 2024
New hires and promotions in the biopharma industry, including: Verastem.
Read More

Appointments and advancements for April 19, 2024

April 19, 2024
New hires and promotions in the med-tech industry, including: Avive, Lifeward, Neurometrix, Numotion, Rewalk, Smartcella.
Read More
Previous 1 2 … 91 92 93 94 95 96 97 98 99 … 322 323 Next

Popular Stories

  • AI generated image for researcher developing antisense oligonucleotides

    Bio Korea 2026 kicks off with spotlight on oligonucleotides

    BioWorld
    Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
  • University of Western Australia patents 5-HT2A/B modulators

    BioWorld Science
    University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
  • Neurons

    AA meeting of minds as PTC, Novartis push votoplam in HD

    BioWorld
    What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
  • Alceptor Therapeutics discovers new α2B-adrenoceptor agonists

    BioWorld Science
    Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
  • Glucagon-like peptide-1 receptor (GLP-1R) complex

    Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control

    BioWorld
    A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing